94531-1SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detectionActive
Term Description
This panel contains results for the detection of Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), initially known as 2019-Novel Coronavirus (2019-nCoV), in any respiratory specimen using nucleic acid amplification assays with probe-based detection for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Source: Regenstrief LOINC
Part Description
LP417539-6 SARS coronavirus 2 RNA panel
The Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), first known as 2019 Novel Coronavirus (2019-nCoV), was first identified as the cause of a respiratory illness outbreak, later defined as Coronavirus Disease 2019 (COVID-19), in Wuhan, China. The full genome of the SARS-CoV-2 that causes COVID-19 was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Real time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) tests targeting regions within genes, including RdRp, S, N, M, and E genes, specific to SARS-CoV-2 have been developed by the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and others for the diagnosis of COVID-19. Some assays only detect SARS-CoV-2 and other assays detect other strains (e.g. SARS-CoV) that are genetically similar.[CDC:coronavirus/2019-ncov][https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance]
Source: Regenstrief LOINC
Panel Hierarchy
Details for each LOINC in Panel
LHC-Forms
| LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
|---|---|---|---|---|
| 94531-1 | SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection | |||
| Indent94500-6 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with probe detection | |||
| Indent94745-7 | SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | {Ct_value} | ||
| Indent96763-8 | SARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory specimen by NAA with probe detection | |||
| Indent96764-6 | SARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | {Ct_value} | ||
| Indent94533-7 | SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by NAA with probe detection | |||
| Indent94757-2 | SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N2 | |||
| Indent94756-4 | SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1 | |||
| Indent95522-9 | SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory specimen by NAA with probe detection | {Log_copies}/mL | ||
| Indent95521-1 | SARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory specimen by NAA with probe detection | {copies}/mL | ||
| Indent94534-5 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Respiratory specimen by NAA with probe detection | |||
| Indent94646-7 | SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | {Ct_value} | ||
| Indent94559-2 | SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection | |||
| Indent94644-2 | SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | {Ct_value} | ||
| Indent94640-0 | SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by NAA with probe detection | |||
| Indent94642-6 | SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | {Ct_value} | ||
| Indent94758-0 | SARS-related coronavirus E gene [Presence] in Respiratory specimen by NAA with probe detection | |||
| Indent94502-2 | SARS-related coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection | |||
| Indent94532-9 | SARS-related coronavirus+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection |
Fully-Specified Name
- Component
- SARS coronavirus 2 RNA panel
- Property
- -
- Time
- Pt
- System
- Respiratory
- Scale
- -
- Method
- Probe.amp.tar
Additional Names
- Short Name
- SARS-CoV-2 RNA Pnl Resp NAA+probe
- Display Name
- SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Resp)
- Consumer Name Alpha
- SARS-CoV-2 (COVID-19) RNA Panel, Respiratory
Ask At Order Entry
This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.
| LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
|---|---|---|---|---|
| 81959-9 | Public health laboratory ask at order entry panel | |||
| Indent81744-5 | Submitter's laboratory test method [Type] in Specimen | |||
| Indent81658-7 | Suspected organism [Identifier] in Specimen | |||
| Indent86952-9 | Preliminary testing done Specimen | |||
| Indent86953-7 | Preliminary testing result Specimen | |||
| Indent86955-2 | Preliminary testing affected submission for further testing Specimen | |||
| Indent95417-2 | Whether this is the patient's first test for condition of interest | |||
| Indent95418-0 | Whether patient is employed in a healthcare setting | |||
| Indent95419-8 | Whether the patient has symptoms related to condition of interest | |||
| Indent11368-8 | Illness or injury onset date and time | C | ||
| Indent77974-4 | Whether the patient was hospitalized for condition of interest | |||
| Indent95420-6 | Whether the patient was admitted to intensive care unit (ICU) for condition of interest | |||
| Indent95421-4 | Whether patient resides in a congregate care setting | |||
| Indent82810-3 | Pregnancy status | C | ||
| Indent30525-0 | Age | a |
Basic Attributes
- Class
- PANEL.MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.69
- Order vs. Observation
- Order
- Panel Type
- Panel
Member of these Groups
| LG51017-8 | SARSCoV2 detection |
| LG51019-4 | SARSCoV2 molecular detection |
Language Variants Get Info
- zh-CNChinese (China)
- SARS 冠状病毒 2 RNA 组套:
-: 时间点: 呼吸道: -: 探针法.基因扩增.靶向 - nl-NLDutch (Netherlands)
- SARS-CoV-2 RNA panel:
-: moment: luchtwegen: -: moleculaire techniek (PCR) - fr-CAFrench (Canada)
- Coronavirus 2 du SRAS, ARN:
-: Temps ponctuel: Respiratoire: -: Sonde avec amplification de la cible - fr-FRFrench (France)
- Coronavirus SARS-CoV-2 ARN panel:
-: Ponctuel: Respiratoire: -: PCR amplification de cible - it-ITItalian (Italy)
- SARS coronavirus 2, panel RNA:
-: Pt: Respiratorio: -: Sonda.amp.tar - es-ESSpanish (Spain)
- Panel de ARN del SARS-CoV-2 (COVID-19):
Propiedades mixtas (sólo paneles): Punto temporal: Respiratorio: -: Sonda con amplificación dirigida
LOINC FHIR® API Example - CodeSystem and Questionnaire Requests Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94531-1
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/94531-1
LOINC Copyright
Copyright © 2021 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright